Objective: To determine the mechanisms by which a traditional herbal medicine, Senkinnaidakusan (SKNS), controls Th2 responses, we examined the production of IL-12 by murine macrophages treated with SKNS.
Introduction
Allergic rhinitis is an inflammatory disease associated with a Th2 response, airway infiltration by eosinophils, and nasal hyper-reactivity (1) (2) (3) (4) (5) . Naive clusters of differentiation (CD) 4 IgE isotype switching (6) (7) (8) . When the same allergen is inhaled, the allergen crosslinks IgE bound to high-affinity FceR on mast cells lining the nasal mucosa, which consequently release stored mediators by granule exocytosis and synthesize leukotrienes and cytokines. Naive CD4 + T cells that polarize into Th1 cells in the presence of IL-12, IL-15, IL-18 and IFN-g, secrete IL-2, IFN-g and tumor necrosis factor (TNF)-a not only for induction of cell-mediated immunity but also for down-regulation of Th2 responses (9) (10) (11) . Therefore, cytokines involved in Th1-biased response are thought to regulate Th2-mediated allergic response.
Many kinds of traditional Japanese herbal medicines have immunomodulating activities, e.g., B cell mitogenic activity (12) , activation of macrophages (13) , enhancement of natural killer (NK) cell activity (14) and actions on hematopoietic stem cells (15) . Senn-kinn-naidaku-sann (SKNS), a traditional Japanese medicine originating in China, is composed of 9 species of medicinal plants and is used for treatment of symptoms such as general fatigue due to weakness and infection. However, the immunological mechanism of SKNS is not known. Recently, Buzhong-yi-qi-tang was reported to up-regulate Toll-like receptor (TLR)-4 expression on monocytes (16) . Toll-like receptors (TLRs) have been shown to play important roles in the recognition of bacterial components (17) . In mice, 10 members of the TLR family have so far been reported (18) . Among TLRs, TLR4 mediates LPS signal transduction in collaboration with other molecules, such as CD14, MD-2, myeloid differentiation factor 88 (MyD88), and Toll receptor-IL-1R domain-containing adaptor protein (TIRAP)/ MyD88-adaptor-like (Mal) (17) (18) (19) (20) . Traditional medicine, which is considered to be effective for infection, may influence TLR4 expression in macrophages and thereby on IL-12 production.
In this study, we examined the effects of SKNS on a murine allergic rhinitis model by enhancement of IL-12 production from macrophages via up-regulation of TLR-4 expression. We used C3H/HeN mice and C3H/HeJ mice, lacking the TLR-4 signaling pathway, to investigate the effect of SKNS on TLR-4.
Materials and methods

Mice
Female C3H/HeN and HeJ mice were obtained from Japan SLC (Hamamatsu, Japan) and used at 7-9 weeks of age.
Cells
All cell lines were grown in tissue culture flasks at 37°C in 5% CO 2 /95% air and passaged every 2 or 3 days to maintain loga- Briefly, peritoneal exudates suspended in RPMI containing 10% FCS were cultured in plastic plates for 1 h at 37°C, non-adherent cells were removed, and fresh, complete medium was added to the adherent cells with or without stimulants.
Reagents and antibodies
Spray-dried SKNS was manufactured by Tsumura (Tokyo, Japan) as the test drug. SKNS was prepared as a hot water extracted from 9 species of medicinal plants, including Ginseng Radix 3g, Angelicae Radix 3g, Astragali Radix 3g, Cnidii Rhizoma 2g, Sinomeni Caulis et Rhizoma 2g, Platycodi Radix 2g, Magnoliae Cortex 2g, Angelicae Dahuricae Radix 1g and Glycyrrhizae Radix 1g.
Extraction was carried out by boiling the mixture of herbs in 10 parts water at 95-100°C for 1 h, and the extract was spray-dried in a hot air stream (21) . LPS from Escherichia coli serotype B6:026, anisomycin, phorbol myristate acetate (PMA), dicoumarol, and p-nitrophenyl phosphate (pNPP) were obtained from Sigma Chemical Co. Concentrations of IL-4, IL-12 p40 and IFN-g in the culture supernatants were measured by using commercial ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. Anti-murine monoclonal IL-5 and IL-13 antibodies for use in Western blotting assay were purchased from Genzyme (Minneapolis, MA, USA).
Reverse transcription-PCR
Total cellular RNA from Raw264.7, HEK293 and mouse peritoneal macrophages was extracted with RNAzol B (Tel-Test, Friendswood, TX, USA) using a single-step isolation method (22) according to the manufacturer's instructions. RNase-free DNase (Takara Biochemicals, Shiga, Japan) was used to remove genomic DNA based on methods described previously (23) . Two micrograms of extracted RNA was reverse-transcribed into first-strand cDNA at 42°C for 40 min using 100 U/ml of reverse transcriptase (RT; Takara Biomedicals) and 0.1 µM oligo(dT) adapter primer 
Western blot analysis
Proteins were obtained from the nasal mucosa of each mouse 12 hours after the final nasal challenge by using lysis buffer (50 mM Hepes, pH 7.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 10 mM NaPPi, 1 mM Na 3 VO 4 , 1 mM phenylmethanesulfonyl fluoride with aprotinin and leupeptin at 10 µg/ml). Samples were centrifuged (15000 rpm, 5 min), and the supernatants were stored at 80°C for further experiments. Lysates were analyzed on a 15% SDS-polyacrylamide gel, and the proteins were transferred to Immobilon polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 1% bovine serum albumin in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 h, and Western blot analysis was performed, followed by detection using an enhanced chemiluminescence system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Immunization and treatment
Mice were each intraperitoneally immunized with 100 mg OVA absorbed on 100 ml of Alum on days 0 and 7. This was followed by daily intranasal (i.n.) challenge with 25 mg of OVA diluted by sterile normal saline from day 21 to day 28. In the SKNS treatment group, mice were orally administered with SKNS (suspended in phosphate-buffered saline (PBS)) or PBS everyday on days 1-8 using gastric tubes. Sera were obtained at 2-week intervals after immunization and stored at -20°C until analysis.
Spleen cells were prepared 24 h after the last inhalation.
Measurement of OVA-specific IgE, IgG1 and IgG2a
Levels of OVA-specific IgE, IgG1 and IgG2a were determined by ELISA. Sample wells of an ELISA plate were coated with OVA overnight and then blocked with 1% BSA in borate-buffered saline (0.05 M borate, 0.15 M NaCl, pH 8.6, 100 ml/well) at 37°C for 30 min. Diluted samples (100 ml/well) were incubated for 90 min at room temperature (Samples for IgE, IgG1 and IgG2a were diluted 1:100, 1:1,000 and 1:5, respectively). The plates were washed with borate-buffered saline with 0.05% Tween 20 and incubated with peroxidase-conjugated anti-mouse IgE, IgG1or IgG2a (Nordic Immunology) for 90 min at room temperature. After further washing, the plates were incubated for 20 min at room temperature with 100 ml/well of o-phenylendiamine solution (1 mg/ml with 3% H 2 O 2 ), and OD was read at 492 nm (23, 24) .
Measurement of cytokine production by spleen cells
Spleen cells were incubated on a nylon wool column at 37°C in 5% CO 2 for 60 min. T cells (5×10 (23, 24) .
Evaluation of nasal signs
Before the last i.n. challenge with OVA or PBS, mice were placed in an observation cage (one animal/cage) for about 10 min for acclimatization. After the i.n. challenge with OVA or PBS, mice were placed in the observation cage again and the number of sneezes were counted for 5 min by the method of Sugimoto et al. (25) .
Histological examination
Mice were killed 12 hr after the last i.n. challenge with OVA or PBS. The heads were removed and fixed in 10% formaldehyde solution for 24 hr at room temperature. After fixation, the heads were decalcificated in 5% formic acid for 36 hr at room temperature and neutralized in 5% sodium sulfate solution for 12 hr at room temperature. Coronal nasal sections were then stained with hematoxylin and eosin, and the number of eosinophils in each side of the posterior edge of the nasal septum was counted microscopically using Image Pro Plus Imaging software (Media Cybernetics, Del Mar, CA, USA).
Statistical analysis
Statistical significance of the data was determined by Student's t-test. A value of p < 0.05 was taken as significant.
Results
Gene expression of TLR4 in Raw264.7 cells after SKNS treatment and LPS stimulation
We examined the expression of TLR4 mRNA in Raw264.7 cells. 
Induction of IL-12 production by Raw264.7 cells after SKNS or LPS stimulation
As shown in Figure 2A , a large amount of IL-12 is released from Raw264.7 cells after stimulation with LPS for 24 h, but SKNS stimulation alone had no effect on IL-12 production. On the other hand, when Raw 264.7 cells were prestimulated with 10 mg/ml of SKNS and LPS, IL-12 production was significantly increased Figure 3B ). Thus, LPS seems to enhance IL-12 production by macrophages derived from C3H/ HeJ mice via TLR4.
Impaired allergic rhinitis in C3H/HeN mice treated with SKNS
To determine which type of T cell response preferentially developed in mice treated with 1,000 mg/kg of SKNS in the induction phase by OVA sensitization, we assessed OVA-specific IgE/IgG2a production in the serum on day 14 after the first immunization with OVA/Alum. PBS-treated C3H/HeN mice had higher OVA-specific IgE and IgG1 levels in serum than did Western blot analysis.
No enhancement of allergic rhinitis by SKNS in C3H/HeJ mice
OVA-specific IgE and IgG1 levels in serum from SKNS-treated C3H/HeJ mice were not influenced by SKNS treatment ( Figure   6A ). There was also no difference between the level of IL-4 production or between the level of IFN-g production by splenic
T cells in SKNS-treated and PBS-treated C3H/HeJ mice ( Figure   6B ). Moreover, sneezing counts, eosinophilic infiltration and IL-5 expression in nasal mucosa did not decrease even after SKNS treatment ( Figure 7A , 7B, and 7C).
Discussion
In this study, we assessed the efficacy of SKNS treatment in a murine allergic rhinitis model. SKNS is known from experience to be effective for treatment of infectious diseases, though the mechanism of action is not clear. Recently, it has been shown that Bu-zhong-yi-qi-tang, a traditional Japanese medicine, enhances the expression of TLR4 on human monocytes (16) .
Traditional Japanese medicines that are effective for treatment of infectious diseases such as SKNS or Bu-zhong-yi-qi-tang may influence macrophages, particularly via up-regulation of TLR4 expression on macrophages. Since TLR4 mRNA is constitutively expressed in unstimulated macrophages, TLR4 must be essential for the initiation of innate immunity in the first encounter with Gram-negative bacteria that are present in the bowel (26) .
Stimulation of macrophages via TLR4 enhances the production of various cytokines productions including IL-12 (27) , IL-15 (26) , IL-18 (28) , IL-6 (29) and TNF-a (30) . IL-12 is essential for the polarisation of antigen-specific Th1 responses (31) (32) (33) (34) . It is thought that up-regulation of Th1 responses inhibit Th2 responses and the development of atopic diseases (35) (36) (37) (38) (39) (40) . We therefore focused on the role of SKNS in the expression of TLR4 on macrophages and the production of IL-12 by macrophages. Allergic rhinitis is a complex phenomenon driven predominantly by Th2-type cells (1) (2) (3) (4) (5) . Allergic rhinitis is characterized by overproduction of Th2 cytokines, which initiate and sustain allergic asthmatic inflammatory responses by enhancing the production of IgE and the growth (6) , differentiation and recruitment of mast cells, basophils and eosinophils. Recently, it has been reported that treatment with various traditional medicines had a beneficial effect for patients with allergic rhinitis (41) (42) (43) . More recently, Mita reported that Bu-zhong-yi-qi-tang up-regulated TLR4 expression on macrophages (16) . (44) . Clinical studies have demonstrated that reduced IFN-g secretion in neonates is associated with subsequent development of atopy (45) (46) (47) . Furthermore, a predisposition toward the overproduction of Th1 cytokines may protect against atopy, because patients with multiple sclerosis (48) , rheumatoid arthritis (49) or tuberculosis (50) , conditions associated with increased production of Th1 cytokines, have a reduced predisposition toward the development of atopy. Macrophage/dendritic cellderived cytokines such as IL-12, IL-15 and IL-18 are at least partly responsible for early IFN-g production from NK and gd T cells and, consequently Th1 cell differentiation. Alternatively, SKNS may contain ligands for NK and gd T cells and directly stimulate the production of IFN-g. Thus, the results of the present study suggest that methods to enhance IFN-g production might be
clinically useful in the prophylaxis of allergic rhinitis (44) .
In summary, oral administration of SKNS inhibited Th2 respon- 
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